Schizophrenia Epidemiology Forecast 2025-2034

Schizophrenia Epidemiology Forecast Report Coverage

Expert Market Research's “Schizophrenia Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of schizophrenia. It projects the future incidence and prevalence rates of schizophrenia across various populations. The study covers age, gender, and type as major determinants of the schizophrenia-affected population. The report highlights patterns in the prevalence of schizophrenia over time and projects future trends based on multiple variables.

Schizophrenia Disease Overview

Schizophrenia is a chronic brain disorder that is characterized primarily by disconnection from reality, including delusions and hallucinations, disorganized thinking and behavior, and decreased participation in daily activities. It is suggested that a combination of genetics, altered brain structure and chemistry, and environmental factors are involved in the development of this mental disorder. Diagnosis of schizophrenia is based on a detailed psychiatric evaluation, history, and symptom analysis. Brain imaging, such as MRI and CT scans, may show structural abnormalities in the affected patient.

Schizophrenia: Treatment Overview

For the treatment of schizophrenia, a combination of medications, psychotherapy, and support services are used to manage symptoms and improve quality of life. First-generation (haloperidol) and second-generation (olanzapine, risperidone) antipsychotic medications are usually prescribed to control symptoms. Psychotherapy, including cognitive behavioral therapy (CBT) and family therapy, is also a popular treatment option for schizophrenia patients to cope with delusions, and hallucinations, and improve social functioning.

Epidemiology

The schizophrenia epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for schizophrenia by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for schizophrenia and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• There are about 24 million people who are suffering from schizophrenia, with the rate estimated to be 1 in 222 people or 0.45% among adults.
• Schizophrenia is usually diagnosed in the late teens to early thirties, with males typically experiencing symptoms earlier (late teens to early twenties) than females (early twenties to early thirties).
• In 2020, schizophrenia was estimated to affect 1.1% of the population, or about 2.8 million adults aged 18 and older in the United States, as per the Treatment Advocacy Center, a US-based non-profit organization.
• Various studies report that schizophrenia is more common in men than women, with a ratio of around 1.4:1 and onset occurring 3.2 to 4.1 years earlier in males. However, some studies show no lifetime prevalence difference between the genders.

Country-wise Schizophrenia Epidemiology

The schizophrenia epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of schizophrenia varies between countries owing to differences in factors such as genetic predispositions, diagnostic practices, levels of awareness, access to healthcare, cultural perceptions of mental health, and lifestyle factors, among others. It is estimated that around 1% of Americans suffer from schizophrenia, according to the National Institute of Mental Health Disorders.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of schizophrenia based on several factors.
• Schizophrenia Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of schizophrenia are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of schizophrenia epidemiology in the 8 major markets?
• What will be the total number of patients with schizophrenia across the 8 major markets during the forecast period?
• What was the country-wise prevalence of schizophrenia in the 8 major markets in the historical period?
• Which country will have the highest number of schizophrenia patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of schizophrenia during the forecast period of 2025-2034?
• What are the currently available treatments for schizophrenia?
• What are the disease risks, signs, symptoms, and unmet needs of schizophrenia?

Related Reports

Schizophrenia Market

Global Schizophrenia Drugs Market